Last 12 months
Inside the activity.
1 purchase rows · 2 sale rows
Disclosed non-derivative P/S rows, by transaction month. Includes amendments and private transactions.Monthly counts
| Month | Purchases | Sales |
|---|---|---|
| Nov 2025 | 0 | 1 |
| Dec 2025 | 0 | 0 |
| Jan 2026 | 0 | 0 |
| Feb 2026 | 0 | 0 |
| Mar 2026 | 0 | 0 |
| Apr 2026 | 0 | 0 |
| May 2026 | 1 | 1 |
| Jun 2026 | 0 | 0 |
| Jul 2026 | 0 | 0 |
| Aug 2026 | 0 | 0 |
| Sep 2026 | 0 | 0 |
| Oct 2026 | 0 | 0 |
Latest available
Insider transactions
Purchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Owner / reported role | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| April 15, 2021 Filed Apr 16, 2021 16:07 UTC |
Toussaint Claudia SSVP,CSO,Gen Counsel & Corp Sec
|
Exercise / conversionCommon Stock | 5,948 | $37.47 | $222,871.56 |
DisclosureSEC source: 0001209191-21-026945 · doc4.xml · nonDerivative · entry 1 Toussaint Claudia S · CIK 0001421560 · SVP,CSO,Gen Counsel & Corp Sec 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 59,057 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · shares: The sale was made pursuant to a 10b5-1 plan adopted by the reporting person on February 15, 2021. Read SEC document |
| March 29, 2021 Filed Mar 30, 2021 23:21 UTC |
Yarkadas HayatiSenior Vice President
|
Disposition to issuerStock Option (Right to Buy) · Derivative | 5,897 | $0.00 Strike: $63.55 | $0.00 |
DisclosureSEC source: 0001209191-21-023626 · doc4.xml · derivative · entry 4 Yarkadas Hayati · CIK 0001657363 · Senior Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 11,974 Underlying: Common · 5,897 shares Expires 2030-02-27 F4 · derivative.exercise_date: On May 7, 2020 17,871 options were granted. 5,897 options vested on February 27, 2021. 5,898 options are scheduled to vest on February 27, 2022 and 6,076 options are scheduled to vest on February 27, 2023. Read SEC document |
| March 29, 2021 Filed Mar 30, 2021 23:21 UTC |
Yarkadas HayatiSenior Vice President
|
SaleCommon Stock | 550 | $104.23 | $57,324.03 |
DisclosureSEC source: 0001209191-21-023626 · doc4.xml · nonDerivative · entry 3 Yarkadas Hayati · CIK 0001657363 · Senior Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 9,056 F1 · shares: The exercise and sale was made pursuant to a 10b5-1 plan adopted by the reporting person on February 25, 2021. F3 · price: This price represents the weighted average price per share of common stock (each, a "Share") of Xylem Inc. (the "Issuer"). 500 shares were sold at prices ranging from $103.60 and $104.53. 50 shares were sold at a price of $104.75. The Reporting Person undertakes to provide, upon request by the Securities and Exchange Commission staff, the Issuer or a security holder of the Issuer, full information regarding the number of Shares sold at each price Read SEC document |
| March 29, 2021 Filed Mar 30, 2021 23:21 UTC |
Yarkadas HayatiSenior Vice President
|
SaleCommon Stock | 5,897 | $104.29 | $614,971.00 |
DisclosureSEC source: 0001209191-21-023626 · doc4.xml · nonDerivative · entry 2 Yarkadas Hayati · CIK 0001657363 · Senior Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 9,606 F1 · shares: The exercise and sale was made pursuant to a 10b5-1 plan adopted by the reporting person on February 25, 2021. F2 · price: This price represents the weighted average price per share of common stock (each, a "Share") of Xylem Inc. (the "Issuer"). The Reporting Person undertakes to provide, upon request by the Securities and Exchange Commission staff, the Issuer or a security holder of the Issuer, full information regarding the number of Shares sold at each price Read SEC document |
| March 29, 2021 Filed Mar 30, 2021 23:21 UTC |
Yarkadas HayatiSenior Vice President
|
Exercise / conversionCommon Stock | 5,897 | $63.55 | $374,754.35 |
DisclosureSEC source: 0001209191-21-023626 · doc4.xml · nonDerivative · entry 1 Yarkadas Hayati · CIK 0001657363 · Senior Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 15,503 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · shares: The exercise and sale was made pursuant to a 10b5-1 plan adopted by the reporting person on February 25, 2021. Read SEC document |
| March 16, 2021 Filed Mar 18, 2021 16:00 UTC |
Toussaint Claudia SSVP,CSO,Gen Counsel & Corp Sec
|
Disposition to issuerStock Option (Right to Buy) · Derivative | 5,948 | $0.00 Strike: $37.47 | $0.00 |
DisclosureSEC source: 0001209191-21-021745 · doc4.xml · derivative · entry 3 Toussaint Claudia S · CIK 0001421560 · SVP,CSO,Gen Counsel & Corp Sec 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 12,068 Underlying: Common · 5,948 shares Expires 2026-02-24 F4 · derivative.exercise_date: These options are fully vested and exercisable. Read SEC document |
| March 16, 2021 Filed Mar 18, 2021 16:00 UTC |
Toussaint Claudia SSVP,CSO,Gen Counsel & Corp Sec
|
SaleCommon Stock | 5,948 | $102.75 | $611,155.81 |
DisclosureSEC source: 0001209191-21-021745 · doc4.xml · nonDerivative · entry 2 Toussaint Claudia S · CIK 0001421560 · SVP,CSO,Gen Counsel & Corp Sec 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 53,109 F2 · price: This price represents the weighted average price per share of common stock (each, a "Share") of Xylem Inc. (the "Issuer"). 4,489 shares were executed at a range of prices from $102.05 to 102.99. 1,459 shares were executed at a range of prices from $103.06 to $103.98. The Reporting Person undertakes to provide, upon request by the Securities and Exchange Commission staff, the Issuer or a security holder of the Issuer, full information regarding the number of Shares sold at each price. F3 · balance_after: Includes 48,065 shares held by the Claudia S Toussaint Revocable Trust. 4,596 shares were transferred to the Claudia S Toussaint Revocable Trust on March 16, 2021. Read SEC document |
| March 16, 2021 Filed Mar 18, 2021 16:00 UTC |
Toussaint Claudia SSVP,CSO,Gen Counsel & Corp Sec
|
Exercise / conversionCommon Stock | 5,948 | $37.47 | $222,871.56 |
DisclosureSEC source: 0001209191-21-021745 · doc4.xml · nonDerivative · entry 1 Toussaint Claudia S · CIK 0001421560 · SVP,CSO,Gen Counsel & Corp Sec 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 59,057 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · shares: The sale was made pursuant to a 10b5-1 plan adopted by the reporting person on February 15, 2021. Read SEC document |
| March 15, 2021 Filed Mar 17, 2021 17:14 UTC |
TAMBAKERAS MARKOS IDirector
|
SaleCommon Stock | 5,000 | $102.02 | $510,106.50 |
DisclosureSEC source: 0001209191-21-021437 · doc4.xml · nonDerivative · entry 1 TAMBAKERAS MARKOS I · CIK 0001012990 · Director 10b5-1 filing: Not disclosed Ownership: Indirect · By Tambakeras Family Trust Disclosed balance after: 33,062 F1 · price: This price represents the weighted average price per Share of the Issuer. Shares were executed at a price $102.0213 per Share. The Reporting Person undertakes to provide, upon request by the Securities and Exchange Commission staff, the Issuer or a security holder of the Issuer, full information regarding the number of Shares sold at each price. Read SEC document |
| March 05, 2021 Filed Mar 8, 2021 18:35 UTC |
Tarapore KairusSVP & CHRO
|
SaleCommon Stock | 401 | $99.53 | $39,911.53 |
DisclosureSEC source: 0001209191-21-018709 · doc4.xml · nonDerivative · entry 1 Tarapore Kairus · CIK 0001383582 · SVP & CHRO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 14,409 F1 · shares: The sale was made pursuant to a 10b5-1 plan adopted by the reporting person on November 6, 2020. F2 · price: This price represents the weighted average price per share of common stock (each, a "Share") of Xylem Inc. (the "Issuer"). 401 shares were executed at a price of $99.53. The Reporting Person undertakes to provide, upon request by the Securities and Exchange Commission staff, the Issuer or a security holder of the Issuer, full information regarding the number of Shares sold at each price. Read SEC document |
| March 02, 2021 Filed Mar 2, 2021 21:47 UTC |
Sabol Colin RSenior Vice President
|
GrantCommon Stock | 2,935 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-21-016120 · doc4.xml · nonDerivative · entry 2 Sabol Colin R · CIK 0001531414 · Senior Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 30,871 F2 · shares: Reflects an award of restricted stock units pursuant to the Xylem 2011 Omnibus Incentive Plan, that are scheduled to vest in one third increments on March 1, 2022, March 1, 2023 and March 1, 2024. Read SEC document |
| March 01, 2021 Filed Mar 2, 2021 16:03 UTC |
Cerwinka FranzSVP and President, Emerging Ma
|
GrantStock Option (Right to Buy) · Derivative | 6,466 | $0.00 Strike: $102.23 | $0.00 |
DisclosureSEC source: 0001209191-21-015829 · doc4.xml · derivative · entry 3 Cerwinka Franz · CIK 0001813828 · SVP and President, Emerging Ma 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 6,466 Underlying: Common · 6,466 shares Expires 2031-03-01 F4 · derivative.exercise_date: Reflects an award of non-qualified stock options pursuant to the Xylem 2011 Omnibus Incentive Plan, that are scheduled to vest in one third increments on March 1, 2022, March 1, 2023 and March 1, 2024 Read SEC document |
| March 01, 2021 Filed Mar 2, 2021 16:03 UTC |
Cerwinka FranzSVP and President, Emerging Ma
|
GrantCommon Stock | 1,467 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-21-015829 · doc4.xml · nonDerivative · entry 2 Cerwinka Franz · CIK 0001813828 · SVP and President, Emerging Ma 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 12,089 F3 · shares: Reflects an award of restricted stock units pursuant to the Xylem 2011 Omnibus Incentive Plan, that are scheduled to vest in one third increments on March 1, 2022, March 1, 2023 and March 1, 2024 Read SEC document |
| March 01, 2021 Filed Mar 2, 2021 16:13 UTC |
Pine Matthew FrancisSenior Vice President
|
GrantStock Options (Right to Buy) · Derivative | 11,853 | $0.00 Strike: $102.23 | $0.00 |
DisclosureSEC source: 0001209191-21-015874 · doc4.xml · derivative · entry 3 Pine Matthew Francis · CIK 0001807057 · Senior Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 11,853 Underlying: Common · 11,853 shares Expires 2031-03-01 F3 · derivative.exercise_date: Reflects an award of non-qualified stock options pursuant to the Xylem 2011 Omnibus Incentive Plan, that are scheduled to vest in one third increments on March 1, 2022, March 1, 2023 and March 1, 2024 Read SEC document |
| March 01, 2021 Filed Mar 2, 2021 16:13 UTC |
Pine Matthew FrancisSenior Vice President
|
GrantCommon Stock | 2,690 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-21-015874 · doc4.xml · nonDerivative · entry 2 Pine Matthew Francis · CIK 0001807057 · Senior Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 53,830 F2 · shares: Reflects an award of restricted stock units pursuant to the Xylem 2011 Omnibus Incentive Plan, that are scheduled to vest in one third increments on March 1, 2022, March 1, 2023 and March 1, 2024 Read SEC document |
| March 01, 2021 Filed Mar 2, 2021 22:05 UTC |
Rowland Sandra E.Chief Financial Officer
|
GrantStock Options (right to buy) · Derivative | 18,319 | $0.00 Strike: $102.23 | $0.00 |
DisclosureSEC source: 0001209191-21-016165 · doc4.xml · derivative · entry 3 Rowland Sandra E. · CIK 0001629360 · Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 18,319 Underlying: Common · 18,319 shares Expires 2031-03-01 F3 · derivative.exercise_date: Reflects an award of non-qualified stock options pursuant to the Xylem 2011 Omnibus Incentive Plan, that are scheduled to vest in one third increments on March 1, 2022, March 1, 2023 and March 1, 2024 Read SEC document |
| March 01, 2021 Filed Mar 2, 2021 22:05 UTC |
Rowland Sandra E.Chief Financial Officer
|
GrantCommon Stock | 4,157 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-21-016165 · doc4.xml · nonDerivative · entry 2 Rowland Sandra E. · CIK 0001629360 · Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 8,416 F2 · shares: Reflects an award of restricted stock units pursuant to the Xylem 2011 Omnibus Incentive Plan, that are scheduled to vest in one third increments on March 1, 2022, March 1, 2023 and March 1, 2024 Read SEC document |
| March 01, 2021 Filed Mar 2, 2021 16:53 UTC |
Toussaint Claudia SSVP, GC & Corporate Secretary
|
GrantStock Option (Right to Buy) · Derivative | 9,698 | $0.00 Strike: $102.23 | $0.00 |
DisclosureSEC source: 0001209191-21-016145 · doc4.xml · derivative · entry 3 Toussaint Claudia S · CIK 0001421560 · SVP, GC & Corporate Secretary 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 9,698 Underlying: Common · 9,698 shares Expires 2031-03-01 F4 · derivative.exercise_date: Reflects an award of non-qualified stock options pursuant to the Xylem 2011 Omnibus Incentive Plan, that are scheduled to vest in one third increments on March 1, 2022, March 1, 2023 and March 1, 2024 Read SEC document |
| March 01, 2021 Filed Mar 2, 2021 16:53 UTC |
Toussaint Claudia SSVP, GC & Corporate Secretary
|
GrantCommon Stock | 2,201 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-21-016145 · doc4.xml · nonDerivative · entry 2 Toussaint Claudia S · CIK 0001421560 · SVP, GC & Corporate Secretary 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 53,109 F2 · shares: Reflects an award of restricted stock units pursuant to the Xylem 2011 Omnibus Incentive Plan, that are scheduled to vest in one third increments on March 1, 2022, March 1, 2023 and March 1, 2024 F3 · balance_after: Includes 43,469 shares held by the Claudia S Toussaint Revocable Trust Read SEC document |
| March 01, 2021 Filed Mar 2, 2021 16:05 UTC |
Decker PatrickDirector · President & CEO
|
GrantStock Option (Right to Buy) · Derivative | 64,655 | $0.00 Strike: $102.23 | $0.00 |
DisclosureSEC source: 0001209191-21-015833 · doc4.xml · derivative · entry 3 Decker Patrick · CIK 0001403434 · Director · President & CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 64,655 Underlying: Common · 64,655 shares Expires 2031-03-01 F3 · derivative.exercise_date: Reflects an award of non-qualified stock options pursuant to the Xylem 2011 Omnibus Incentive Plan, that are scheduled to vest in one third increments on March 1, 2022, March 1, 2023 and March 1, 2024 Read SEC document |
| March 01, 2021 Filed Mar 2, 2021 16:05 UTC |
Decker PatrickDirector · President & CEO
|
GrantCommon Stock | 14,673 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-21-015833 · doc4.xml · nonDerivative · entry 2 Decker Patrick · CIK 0001403434 · Director · President & CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 265,353 F2 · shares: Reflects an award of restricted stock units pursuant to the Xylem 2011 Omnibus Incentive Plan, that are scheduled to vest in one third increments on March 1, 2022, March 1, 2023 and March 1, 2024 Read SEC document |
| March 01, 2021 Filed Mar 2, 2021 16:51 UTC |
Tarapore KairusSVP & CHRO
|
GrantStock Option (Right to Buy) · Derivative | 6,843 | $0.00 Strike: $102.23 | $0.00 |
DisclosureSEC source: 0001209191-21-016136 · doc4.xml · derivative · entry 4 Tarapore Kairus · CIK 0001383582 · SVP & CHRO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 6,843 Underlying: Common · 6,843 shares Expires 2031-03-01 F5 · derivative.exercise_date: Reflects an award of non-qualified stock options pursuant to the Xylem 2011 Omnibus Incentive Plan, that are scheduled to vest in one third increments on March 1, 2022, March 1, 2023 and March 1, 2024. Read SEC document |
| March 01, 2021 Filed Mar 2, 2021 16:51 UTC |
Tarapore KairusSVP & CHRO
|
GrantCommon Stock | 1,553 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-21-016136 · doc4.xml · nonDerivative · entry 3 Tarapore Kairus · CIK 0001383582 · SVP & CHRO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 14,810 F4 · shares: Reflects an award of restricted stock units pursuant to the Xylem 2011 Omnibus Incentive Plan, that are scheduled to vest in one third increments on March 1, 2022, March 1, 2023 and March 1, 2024 Read SEC document |
| March 01, 2021 Filed Mar 2, 2021 21:47 UTC |
Sabol Colin RSenior Vice President
|
GrantStock Option (Right to Buy) · Derivative | 12,931 | $0.00 Strike: $102.23 | $0.00 |
DisclosureSEC source: 0001209191-21-016120 · doc4.xml · derivative · entry 3 Sabol Colin R · CIK 0001531414 · Senior Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 12,931 Underlying: Common · 12,931 shares Expires 2031-03-01 F3 · derivative.exercise_date: Reflects an award of non-qualified stock options pursuant to the Xylem 2011 Omnibus Incentive Plan, that are scheduled to vest in one third increments on March 1, 2022, March 1, 2023 and March 1, 2024 Read SEC document |
| March 01, 2021 Filed Mar 2, 2021 21:55 UTC |
Yarkadas HayatiSenior Vice President
|
GrantStock Option (Right to Buy) · Derivative | 9,698 | $0.00 Strike: $102.23 | $0.00 |
DisclosureSEC source: 0001209191-21-016150 · doc4.xml · derivative · entry 3 Yarkadas Hayati · CIK 0001657363 · Senior Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 9,698 Underlying: Common · 9,698 shares Expires 2031-03-01 F4 · derivative.exercise_date: Reflects an award of non-qualified stock options pursuant to the Xylem 2011 Omnibus Incentive Plan, that are scheduled to vest in one third increments on March 1, 2022, March 1, 2023 and March 1, 2024 Read SEC document |
| March 01, 2021 Filed Mar 2, 2021 21:55 UTC |
Yarkadas HayatiSenior Vice President
|
GrantCommon Stock | 2,201 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-21-016150 · doc4.xml · nonDerivative · entry 2 Yarkadas Hayati · CIK 0001657363 · Senior Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 9,606 F3 · shares: Reflects an award of restricted stock units pursuant to the Xylem 2011 Omnibus Incentive Plan, that are scheduled to vest in one third increments on March 1, 2022, March 1, 2023 and March 1, 2024 Read SEC document |
| March 01, 2021 Filed Mar 2, 2021 21:09 UTC |
McShane Geri-MichelleChief Accounting Officer
|
GrantStock Options (Right to Buy) · Derivative | 2,694 | $0.00 Strike: $102.23 | $0.00 |
DisclosureSEC source: 0001209191-21-015857 · doc4.xml · derivative · entry 3 McShane Geri-Michelle · CIK 0001769064 · Chief Accounting Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 2,694 Underlying: Common · 2,694 shares Expires 2031-03-01 F3 · derivative.exercise_date: Reflects an award of non-qualified stock options pursuant to the Xylem 2011 Omnibus Incentive Plan, that are scheduled to vest in one third increments on March 1, 2022, March 1, 2023 and March 1, 2024 Read SEC document |
| March 01, 2021 Filed Mar 2, 2021 21:09 UTC |
McShane Geri-MichelleChief Accounting Officer
|
GrantCommon Stock | 611 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-21-015857 · doc4.xml · nonDerivative · entry 2 McShane Geri-Michelle · CIK 0001769064 · Chief Accounting Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 2,454 F2 · shares: Reflects an award of restricted stock units pursuant to the Xylem 2011 Omnibus Incentive Plan, that are scheduled to vest in one third increments on March 1, 2022, March 1, 2023 and March 1, 2024 Read SEC document |
| March 01, 2021 Filed Mar 2, 2021 21:06 UTC |
Flinton DavidSenior Vice President
|
GrantStock Option (Right to Buy) · Derivative | 8,082 | $0.00 Strike: $102.23 | $0.00 |
DisclosureSEC source: 0001209191-21-015848 · doc4.xml · derivative · entry 3 Flinton David · CIK 0001654800 · Senior Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 8,082 Underlying: Common · 8,082 shares Expires 2031-03-01 F3 · derivative.exercise_date: Reflects an award of non-qualified stock options pursuant to the Xylem 2011 Omnibus Incentive Plan, that are scheduled to vest in one third increments on March 1, 2022, March 1, 2023 and March 1, 2024 Read SEC document |
| March 01, 2021 Filed Mar 2, 2021 21:06 UTC |
Flinton DavidSenior Vice President
|
GrantCommon Stock | 1,834 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-21-015848 · doc4.xml · nonDerivative · entry 2 Flinton David · CIK 0001654800 · Senior Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 26,299 F2 · shares: Reflects an award of restricted stock units pursuant to the Xylem 2011 Omnibus Incentive Plan, that are scheduled to vest in one third increments on March 1, 2022, March 1, 2023 and March 1, 2024 Read SEC document |
| February 27, 2021 Filed Mar 2, 2021 16:03 UTC |
Cerwinka FranzSVP and President, Emerging Ma
|
SaleCommon Stock | 288 | $101.80 | $29,317.74 |
DisclosureSEC source: 0001209191-21-015829 · doc4.xml · nonDerivative · entry 1 Cerwinka Franz · CIK 0001813828 · SVP and President, Emerging Ma 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 10,622 F1 · shares: Reflects the sale of common stock to pay the tax liability incident to the vesting of restricted stock units granted on Feb 27, 2020 under the Xylem 2011 Omnibus Incentive Plan F2 · price: This price represents the weighted average price per share of common stock (each, a "Share") of Xylem Inc. (the "Issuer"). 288 shares that were executed at price of $101.7977. The Reporting Person undertakes to provide, upon request by the Securities and Exchange Commission staff, the Issuer or a security holder of the Issuer, full information regarding the number of Shares sold at each price Read SEC document |
| February 27, 2021 Filed Mar 2, 2021 16:13 UTC |
Pine Matthew FrancisSenior Vice President
|
Disposition to issuerCommon Stock | 394 | $102.23 | $40,278.62 |
DisclosureSEC source: 0001209191-21-015874 · doc4.xml · nonDerivative · entry 1 Pine Matthew Francis · CIK 0001807057 · Senior Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 51,140 F1 · shares: Reflects the withholding of common stock to pay the tax liability incident to the vesting of restricted stock units granted on Feb 27, 2020 under the Xylem 2011 Omnibus Incentive Plan Read SEC document |
| February 27, 2021 Filed Mar 2, 2021 22:05 UTC |
Rowland Sandra E.Chief Financial Officer
|
Tax withholdingCommon Stock | 538 | $102.23 | $54,999.74 |
DisclosureSEC source: 0001209191-21-016165 · doc4.xml · nonDerivative · entry 1 Rowland Sandra E. · CIK 0001629360 · Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 4,259 F1 · shares: Reflects the withholding of common stock to pay the tax liability incident to the vesting of restricted stock units granted on Feb 27, 2020 under the Xylem 2011 Omnibus Incentive Plan Read SEC document |
| February 27, 2021 Filed Mar 2, 2021 16:53 UTC |
Toussaint Claudia SSVP, GC & Corporate Secretary
|
Tax withholdingCommon Stock | 313 | $102.23 | $31,997.99 |
DisclosureSEC source: 0001209191-21-016145 · doc4.xml · nonDerivative · entry 1 Toussaint Claudia S · CIK 0001421560 · SVP, GC & Corporate Secretary 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 50,908 F1 · shares: Reflects the withholding of common stock to pay the tax liability incident to the vesting of restricted stock units granted on Feb 27, 2020 under the Xylem 2011 Omnibus Incentive Plan Read SEC document |
| February 27, 2021 Filed Mar 2, 2021 16:05 UTC |
Decker PatrickDirector · President & CEO
|
Tax withholdingCommon Stock | 3,135 | $102.23 | $320,491.05 |
DisclosureSEC source: 0001209191-21-015833 · doc4.xml · nonDerivative · entry 1 Decker Patrick · CIK 0001403434 · Director · President & CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 250,680 F1 · shares: Reflects the withholding of common stock to pay the tax liability incident to the vesting of restricted stock units granted on Feb 27, 2020 under the Xylem 2011 Omnibus Incentive Plan Read SEC document |
| February 27, 2021 Filed Mar 2, 2021 16:51 UTC |
Tarapore KairusSVP & CHRO
|
Tax withholdingCommon Stock | 249 | $102.23 | $25,455.27 |
DisclosureSEC source: 0001209191-21-016136 · doc4.xml · nonDerivative · entry 2 Tarapore Kairus · CIK 0001383582 · SVP & CHRO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 13,257 F3 · shares: Reflects the withholding of common stock to pay the tax liability incident to the vesting of restricted stock units granted on Feb 27, 2020 under the Xylem 2011 Omnibus Incentive Plan Read SEC document |
| February 27, 2021 Filed Mar 2, 2021 21:47 UTC |
Sabol Colin RSenior Vice President
|
Tax withholdingCommon Stock | 365 | $102.23 | $37,313.95 |
DisclosureSEC source: 0001209191-21-016120 · doc4.xml · nonDerivative · entry 1 Sabol Colin R · CIK 0001531414 · Senior Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 27,936 F1 · shares: Reflects the withholding of common stock to pay the tax liability incident to the vesting of restricted stock units granted on Feb 27, 2020 under the Xylem 2011 Omnibus Incentive Plan Read SEC document |
| February 27, 2021 Filed Mar 2, 2021 21:55 UTC |
Yarkadas HayatiSenior Vice President
|
SaleCommon Stock | 70 | $101.80 | $7,125.84 |
DisclosureSEC source: 0001209191-21-016150 · doc4.xml · nonDerivative · entry 1 Yarkadas Hayati · CIK 0001657363 · Senior Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 7,405 F1 · shares: Reflects the sale of common stock to pay the tax liability incident to the vesting of restricted stock units granted on Feb 27, 2020 under the Xylem 2011 Omnibus Incentive Plan F2 · price: This price represents the weighted average price per share of common stock (each, a "Share") of Xylem Inc. (the "Issuer"). 70 shares that were executed at price of $101.7977. The Reporting Person undertakes to provide, upon request by the Securities and Exchange Commission staff, the Issuer or a security holder of the Issuer, full information regarding the number of Shares sold at each price Read SEC document |
| February 27, 2021 Filed Mar 2, 2021 21:09 UTC |
McShane Geri-MichelleChief Accounting Officer
|
Tax withholdingCommon Stock | 70 | $102.23 | $7,156.10 |
DisclosureSEC source: 0001209191-21-015857 · doc4.xml · nonDerivative · entry 1 McShane Geri-Michelle · CIK 0001769064 · Chief Accounting Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,843 F1 · shares: Reflects the withholding of common stock to pay the tax liability incident to the vesting of restricted stock units granted on Feb 27, 2020 under the Xylem 2011 Omnibus Incentive Plan Read SEC document |
| February 27, 2021 Filed Mar 2, 2021 21:06 UTC |
Flinton DavidSenior Vice President
|
Tax withholdingCommon Stock | 226 | $102.23 | $23,103.98 |
DisclosureSEC source: 0001209191-21-015848 · doc4.xml · nonDerivative · entry 1 Flinton David · CIK 0001654800 · Senior Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 24,465 F1 · shares: Reflects the withholding of common stock to pay the tax liability incident to the vesting of restricted stock units granted on Feb 27, 2020 under the Xylem 2011 Omnibus Incentive Plan Read SEC document |
| February 26, 2021 Filed Mar 2, 2021 16:51 UTC |
Tarapore KairusSVP & CHRO
|
SaleCommon Stock | 2,777 | $99.95 | $277,561.15 |
DisclosureSEC source: 0001209191-21-016136 · doc4.xml · nonDerivative · entry 1 Tarapore Kairus · CIK 0001383582 · SVP & CHRO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 13,506 F1 · shares: The sale was made pursuant to a 10b5-1 plan adopted by the reporting person on November 6, 2020. F2 · price: This price represents the weighted average price per share of common stock (each, a "Share") of Xylem Inc. (the "Issuer"). 2,777 shares that were executed at price of $99.95. The Reporting Person undertakes to provide, upon request by the Securities and Exchange Commission staff, the Issuer or a security holder of the Issuer, full information regarding the number of Shares sold at each price. Read SEC document |
| February 21, 2021 Filed Feb 23, 2021 19:41 UTC |
Toussaint Claudia SSVP, GC & Corporate Secretary
|
Tax withholdingCommon Stock | 1,443 | $99.48 | $143,549.64 |
DisclosureSEC source: 0001209191-21-013477 · doc4.xml · nonDerivative · entry 4 Toussaint Claudia S · CIK 0001421560 · SVP, GC & Corporate Secretary 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 51,221 F4 · shares: Reflects the withholding of common stock to pay the tax liability incident to the vesting of performance-based restricted stock units granted on Feb 21, 2018 under the Xylem 2011 Omnibus Incentive Plan F5 · balance_after: Includes 43,469 shares held by the Claudia S Toussaint Revocable Trust Read SEC document |
| February 21, 2021 Filed Feb 23, 2021 19:41 UTC |
Toussaint Claudia SSVP, GC & Corporate Secretary
|
GrantCommon Stock | 4,256 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-21-013477 · doc4.xml · nonDerivative · entry 3 Toussaint Claudia S · CIK 0001421560 · SVP, GC & Corporate Secretary 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 52,664 F3 · shares: Reflects the acquisition of 4,256 shares of common stock upon vesting of performance-based restricted stock units granted on February 21, 2018 upon achievement of performance criteria related to Total Shareholder Return, under the Xylem 2011 Omnibus Incentive Plan. Read SEC document |
| February 21, 2021 Filed Feb 23, 2021 19:41 UTC |
Toussaint Claudia SSVP, GC & Corporate Secretary
|
Tax withholdingCommon Stock | 301 | $99.48 | $29,943.48 |
DisclosureSEC source: 0001209191-21-013477 · doc4.xml · nonDerivative · entry 2 Toussaint Claudia S · CIK 0001421560 · SVP, GC & Corporate Secretary 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 48,408 F2 · shares: Reflects the withholding of common stock to pay the tax liability incident to the vesting of restricted stock units granted on Feb 21, 2018 under the Xylem 2011 Omnibus Incentive Plan Read SEC document |
| February 21, 2021 Filed Feb 23, 2021 19:15 UTC |
Decker PatrickDirector · President & CEO
|
Tax withholdingCommon Stock | 14,491 | $99.48 | $1,441,564.68 |
DisclosureSEC source: 0001209191-21-013456 · doc4.xml · nonDerivative · entry 4 Decker Patrick · CIK 0001403434 · Director · President & CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 253,815 F4 · shares: Reflects the withholding of common stock to pay the tax liability incident to the vesting of performance-based restricted stock units granted on Feb 21, 2018 under the Xylem 2011 Omnibus Incentive Plan Read SEC document |
| February 21, 2021 Filed Feb 23, 2021 19:15 UTC |
Decker PatrickDirector · President & CEO
|
GrantCommon Stock | 31,125 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-21-013456 · doc4.xml · nonDerivative · entry 3 Decker Patrick · CIK 0001403434 · Director · President & CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 268,306 F3 · shares: Reflects the acquisition of 31,125 shares of common stock upon vesting of performance-based restricted stock units granted on February 21, 2018 upon achievement of performance criteria related to Total Shareholder Return, under the Xylem 2011 Omnibus Incentive Plan. Read SEC document |
| February 21, 2021 Filed Feb 23, 2021 19:15 UTC |
Decker PatrickDirector · President & CEO
|
Tax withholdingCommon Stock | 3,125 | $99.48 | $310,875.00 |
DisclosureSEC source: 0001209191-21-013456 · doc4.xml · nonDerivative · entry 2 Decker Patrick · CIK 0001403434 · Director · President & CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 237,181 F2 · shares: Reflects the withholding of common stock to pay the tax liability incident to the vesting of restricted stock units granted on Feb 21, 2018 under the Xylem 2011 Omnibus Incentive Plan Read SEC document |
| February 21, 2021 Filed Feb 23, 2021 19:40 UTC |
Tarapore KairusSVP & CHRO
|
Tax withholdingCommon Stock | 1,217 | $99.48 | $121,067.16 |
DisclosureSEC source: 0001209191-21-013474 · doc4.xml · nonDerivative · entry 4 Tarapore Kairus · CIK 0001383582 · SVP & CHRO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 16,283 F4 · shares: Reflects the withholding of common stock to pay the tax liability incident to the vesting of performance-based restricted stock units granted on Feb 21, 2018 under the Xylem 2011 Omnibus Incentive Plan Read SEC document |
| February 21, 2021 Filed Feb 23, 2021 19:40 UTC |
Tarapore KairusSVP & CHRO
|
GrantCommon Stock | 3,192 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-21-013474 · doc4.xml · nonDerivative · entry 3 Tarapore Kairus · CIK 0001383582 · SVP & CHRO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 17,500 F3 · shares: Reflects the acquisition of 3,192 shares of common stock upon vesting of performance-based restricted stock units granted on February 21, 2018 upon achievement of performance criteria related to Total Shareholder Return, under the Xylem 2011 Omnibus Incentive Plan. Read SEC document |
| February 21, 2021 Filed Feb 23, 2021 19:40 UTC |
Tarapore KairusSVP & CHRO
|
Tax withholdingCommon Stock | 255 | $99.48 | $25,367.40 |
DisclosureSEC source: 0001209191-21-013474 · doc4.xml · nonDerivative · entry 2 Tarapore Kairus · CIK 0001383582 · SVP & CHRO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 14,308 F2 · shares: Reflects the withholding of common stock to pay the tax liability incident to the vesting of restricted stock units granted on Feb 21, 2018 under the Xylem 2011 Omnibus Incentive Plan Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.